Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis

INTRODUCTION: In STRIVE, natalizumab treatment demonstrated effectiveness in clinical, magnetic resonance imaging (MRI), and patient-reported outcomes (PROs) in patients with early relapsing–remitting multiple sclerosis (RRMS). This post hoc analysis examined the effectiveness and safety of natalizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Perumal, Jai, Balabanov, Roumen, Balcer, Laura, Galetta, Steven, Sun, Zhaonan, Li, Hanyue, Rutledge, Danette, Avila, Robin L., Fox, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195921/
https://www.ncbi.nlm.nih.gov/pubmed/36966440
http://dx.doi.org/10.1007/s40120-023-00461-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195921/
https://www.ncbi.nlm.nih.gov/pubmed/36966440
http://dx.doi.org/10.1007/s40120-023-00461-0

Ejemplares similares